rosuvastatin 5 mg and ezetimibe 10 mg
1 INDICATIONS AND USAGE ROSZET is indicated in adults: As an adjunct to diet in patients with primary non-familial hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C). Alone or as an adjunct to other LDL-C-lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C. ROSZET is a combination of rosuvastatin, an HMG CoA-reductase inhibitor (statin), and ezetimibe, a dietary cholesterol absorption inhibitor, indicated in adults: As an adjunct to diet in patients with primary non-familial hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C). ( 1 ) Alone or as an adjunct to other LDL-C lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C. ( 1 )
Althera Pharmaceuticals LLC
Related Pills
bisacodyl 5 mg
Major Pharmaceuticals
donepezil 5 mg
torrent pharmaceuticals limited
lisinopril tablet
Lupin Pharmaceuticals, Inc.
Acetaminophen 650 mg Hydrocodone 10 mg
watson laboratories, inc.
desloratadine 5 mg oral tablet
virtus pharmaceuticals
BZP hydrochloride 5 MG Oral Tablet
Eon Labs, Inc.
APAP 500 MG Oral Capsule
Geri-Care Pharmaceutical Corp
ranitidine 150 MG as ranitidine hydrochloride 168 MG Oral Tablet
Dr. Reddy's Laboratories Limited
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING ROSZET Tablets are supplied as follows: Strength (Contents) Description Container NDC 5 mg/10 mg (rosuvastatin 5 mg and ezetimibe 10 mg) round pink biconvex tablets with “5” embossed on one side Bottle of 30 tablets and two 1 g desiccants 70661-001-30 10 mg/10 mg (rosuvastatin 10 mg and ezetimibe 10 mg) round pink biconvex tablets with “AL” embossed on one side Bottle of 30 tablets and two 1 g desiccants 70661-002-30 20 mg/10 mg (rosuvastatin 20 mg and ezetimibe 10 mg) round pink biconvex tablets with “II” embossed on one side Bottle of 30 tablets and two 1 g desiccants 70661-003-30 40 mg/10 mg (rosuvastatin 40 mg and ezetimibe 10 mg) round pink biconvex tablets with “77” embossed on one side Bottle of 30 tablets and two 1 g desiccants 70661-004-30 Store at controlled room temperature (USP), 20°C to 25 ºC (68°F to 77 ºF) [see USP Controlled Room Temperature]. Store in the original container to protect from light. Protect from moisture. Once the bottle has been opened, use the tablets within 30 days. Dispense in original container to protect from moisture.
More pills like ROUND 5